In an effort to end the HIV epidemic by 2030, the Joint United Nations Program on HIV/AIDS(UNAIDS)set the ‘90-90-90’ target and aimed to expand the timely use of ART worldwide. By the end of 2017,21.7 million people...In an effort to end the HIV epidemic by 2030, the Joint United Nations Program on HIV/AIDS(UNAIDS)set the ‘90-90-90’ target and aimed to expand the timely use of ART worldwide. By the end of 2017,21.7 million people living with HIV, amounting to59% of HIV patients worldwide, were receiving antiretroviral therapy(ART)[1]. In China, the National Free Antiretroviral Treatment Program(NFATP),which was initiated in 2002, continued to progress.展开更多
Combination antiretroviral therapy(ART)reduced AIDS-related mortality and increased survival among patients living with HIV by interrupting HIV replication,enhancing immune recovery,and preventing the onset of opportu...Combination antiretroviral therapy(ART)reduced AIDS-related mortality and increased survival among patients living with HIV by interrupting HIV replication,enhancing immune recovery,and preventing the onset of opportunistic infections[1].In China,ART has rapidly been scaled up since the beginning of the National Free Antiretroviral Treatment Program(NFATP)in 2003[2].By the end of 2016,489,411 individuals diagnosed with HIV were receiving free antiretroviral treatment in China.China is firmly committed to reducing overall AIDS-related mortality and HIV incidence within the country.However,similar to other low-and middle-income countries,the NFATP is challenged by high mortality and attrition shortly after patients initiate ART[3].展开更多
The Tibet Autonomous Region(referred to as‘Tibet’)is located in southwestern China,bordering the Yunnan Province,Sichuan Province,Xinjiang Uygur Autonomous Region,and other provinces with high HIV/AIDS prevalence,as...The Tibet Autonomous Region(referred to as‘Tibet’)is located in southwestern China,bordering the Yunnan Province,Sichuan Province,Xinjiang Uygur Autonomous Region,and other provinces with high HIV/AIDS prevalence,as well as India,Nepal,and other high-risk border countries.In 1994,the first patient with HIV-1 infection was detected at Zhangmu port,Namu County,Shigatse,Tibet.展开更多
基金supported by the Research Project of Chongqing Municipal Science and Technology Bureau[cstc2019jscx-msxm X0225]Medical Research Project of Chongqing Municipal Health Commission [2017ZDXM001,2019ZDXM005]。
文摘In an effort to end the HIV epidemic by 2030, the Joint United Nations Program on HIV/AIDS(UNAIDS)set the ‘90-90-90’ target and aimed to expand the timely use of ART worldwide. By the end of 2017,21.7 million people living with HIV, amounting to59% of HIV patients worldwide, were receiving antiretroviral therapy(ART)[1]. In China, the National Free Antiretroviral Treatment Program(NFATP),which was initiated in 2002, continued to progress.
基金the Guangxi Medical and Health Project[Z20170126]the National Natural Science Foundation of China[Grant numbers 11971479,81502862,81460510,81360442,and 91546203]+2 种基金Guangxi Science and Technology Bureau[Grant number AB16380213]Guangxi Bagui Honor Scholarship,Ministry of Science and Technology of China[2018ZX10721102-006 and 2017ZX10201101]Guangxi Key Laboratory of AIDS Prevention Control and Translation,and Chinese State Key Laboratory of Infectious Disease Prevention and Control.
文摘Combination antiretroviral therapy(ART)reduced AIDS-related mortality and increased survival among patients living with HIV by interrupting HIV replication,enhancing immune recovery,and preventing the onset of opportunistic infections[1].In China,ART has rapidly been scaled up since the beginning of the National Free Antiretroviral Treatment Program(NFATP)in 2003[2].By the end of 2016,489,411 individuals diagnosed with HIV were receiving free antiretroviral treatment in China.China is firmly committed to reducing overall AIDS-related mortality and HIV incidence within the country.However,similar to other low-and middle-income countries,the NFATP is challenged by high mortality and attrition shortly after patients initiate ART[3].
基金supported by the National Science and Technology Major Project‘Prevention and Control of Major Infectious Diseases such as AIDS and Viral Hepatitis’[2017ZX10201101]special funding for AIDS prevention。
文摘The Tibet Autonomous Region(referred to as‘Tibet’)is located in southwestern China,bordering the Yunnan Province,Sichuan Province,Xinjiang Uygur Autonomous Region,and other provinces with high HIV/AIDS prevalence,as well as India,Nepal,and other high-risk border countries.In 1994,the first patient with HIV-1 infection was detected at Zhangmu port,Namu County,Shigatse,Tibet.
